Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12N2O2 |
Molecular Weight | 240.2573 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC=C2CCC(=CC2=C1)N3C=CN=C3
InChI
InChIKey=DQEDSIVMYUUZCK-UHFFFAOYSA-N
InChI=1S/C14H12N2O2/c17-14(18)11-2-1-10-3-4-13(8-12(10)7-11)16-6-5-15-9-16/h1-2,5-9H,3-4H2,(H,17,18)
Molecular Formula | C14H12N2O2 |
Molecular Weight | 240.2573 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Rolafagrel (FCE 22178) is a selective thromboxane synthase inhibitor that has been evaluated for use in the treatment of diabetic nephropathy and thrombosis. Rolafagrel inhibits platelet and glomerular thromoxane synthase in animal and human kidney disease. A phase I clinical trial did not report drug-related adverse events. No information is available on current use of rolafagrel.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P24557|||Q8IUN1|||Q9HD82 Gene ID: 6916.0 Gene Symbol: TBXAS1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/8473553 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:33:45 GMT 2023
by
admin
on
Fri Dec 15 15:33:45 GMT 2023
|
Record UNII |
OAH71568Y4
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
||
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C96929
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
C066217
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
89781-55-5
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
56009
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
SUB10362MIG
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107064
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
DTXSID30237887
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
100000084349
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
6769
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY | |||
|
OAH71568Y4
Created by
admin on Fri Dec 15 15:33:45 GMT 2023 , Edited by admin on Fri Dec 15 15:33:45 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |